Skip to main content
. 2015 Feb 3;9(2):e0003449. doi: 10.1371/journal.pntd.0003449

Figure 4. Levels of anti-PpSP32 antibodies in patients with active ZCL vary according to the type and size of the lesions.

Figure 4

(a) Anti-SP32 antibody levels were measured in patients with nodular, papular and ulcer type lesions in Al Madinah and (b) Al Ahsa. (c) Comparison of antibody levels according to ZCL lesion size in patients from Al Ahsa (** p≤0.01) and Al Madinah. (d) Antibody levels according to lesion number in Al Ahsa and Al Madinah. Control: healthy individuals; CL: active infection; CR: cured infection; OD: optical density. * P≤ .05; ** P ≤ .01; *** P ≤ .001.